Treatment of severe community-acquired pneumonia with oral amoxicillin in under-five children in developing country: a systematic review.

OBJECTIVE: To assess the evidence regarding efficacy of oral amoxicillin compared to standard treatment for WHO-defined severe community acquired pneumonia in under-five children in developing country. DESIGN: Systematic review and meta-analysis of data from published Randomized trials (RCTs). DATA...

Full description

Bibliographic Details
Main Authors: Rashmi Ranjan Das, Meenu Singh
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3692509?pdf=render
_version_ 1818969917265805312
author Rashmi Ranjan Das
Meenu Singh
author_facet Rashmi Ranjan Das
Meenu Singh
author_sort Rashmi Ranjan Das
collection DOAJ
description OBJECTIVE: To assess the evidence regarding efficacy of oral amoxicillin compared to standard treatment for WHO-defined severe community acquired pneumonia in under-five children in developing country. DESIGN: Systematic review and meta-analysis of data from published Randomized trials (RCTs). DATA SOURCES: MEDLINE (1970- July 2012) via PubMed, Cochrane Central Register of Controlled Trials (CENTRAL, The Cochrane Library, Issue 7, July 2012), and EMBASE (1988- June 2012). METHODS: Eligible trials compared oral amoxicillin administered in ambulatory setting versus standard treatment for WHO-defined severe community acquired pneumonia in children under-five. Primary outcomes were proportion of children developing treatment failure at 48 hr, and day 6. GRADE criteria was used to rate the quality of evidence. RESULTS: Out of 281 full text articles assessed for eligibility, 5 trials including 12364 children were included in the meta-analysis. Oral amoxicillin administered either in hospital or community setting is effective in treatment of severe pneumonia and is not inferior to the standard treatment. None of the clinical predictors of treatment failure by 48 hr (very severe disease, fever and lower chest indrawing, and voluntary with-drawl and loss to follow up) was significant between the two groups. The clinical predictors of treatment failure that were significant by day 6 were very severe disease, inability to drink, change of antibiotic, and fever alone. The effect was almost consistent across the studies. CONCLUSION: Though oral amoxicillin is effective in treatment of severe CAP in under-five children in developing country, the evidence generated is of low-quality. More trials with uniform comparators are needed in order to strengthen the evidence.
first_indexed 2024-12-20T14:28:12Z
format Article
id doaj.art-084a13f57f324afca9b03e0c82833401
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-20T14:28:12Z
publishDate 2013-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-084a13f57f324afca9b03e0c828334012022-12-21T19:37:43ZengPublic Library of Science (PLoS)PLoS ONE1932-62032013-01-0186e6623210.1371/journal.pone.0066232Treatment of severe community-acquired pneumonia with oral amoxicillin in under-five children in developing country: a systematic review.Rashmi Ranjan DasMeenu SinghOBJECTIVE: To assess the evidence regarding efficacy of oral amoxicillin compared to standard treatment for WHO-defined severe community acquired pneumonia in under-five children in developing country. DESIGN: Systematic review and meta-analysis of data from published Randomized trials (RCTs). DATA SOURCES: MEDLINE (1970- July 2012) via PubMed, Cochrane Central Register of Controlled Trials (CENTRAL, The Cochrane Library, Issue 7, July 2012), and EMBASE (1988- June 2012). METHODS: Eligible trials compared oral amoxicillin administered in ambulatory setting versus standard treatment for WHO-defined severe community acquired pneumonia in children under-five. Primary outcomes were proportion of children developing treatment failure at 48 hr, and day 6. GRADE criteria was used to rate the quality of evidence. RESULTS: Out of 281 full text articles assessed for eligibility, 5 trials including 12364 children were included in the meta-analysis. Oral amoxicillin administered either in hospital or community setting is effective in treatment of severe pneumonia and is not inferior to the standard treatment. None of the clinical predictors of treatment failure by 48 hr (very severe disease, fever and lower chest indrawing, and voluntary with-drawl and loss to follow up) was significant between the two groups. The clinical predictors of treatment failure that were significant by day 6 were very severe disease, inability to drink, change of antibiotic, and fever alone. The effect was almost consistent across the studies. CONCLUSION: Though oral amoxicillin is effective in treatment of severe CAP in under-five children in developing country, the evidence generated is of low-quality. More trials with uniform comparators are needed in order to strengthen the evidence.http://europepmc.org/articles/PMC3692509?pdf=render
spellingShingle Rashmi Ranjan Das
Meenu Singh
Treatment of severe community-acquired pneumonia with oral amoxicillin in under-five children in developing country: a systematic review.
PLoS ONE
title Treatment of severe community-acquired pneumonia with oral amoxicillin in under-five children in developing country: a systematic review.
title_full Treatment of severe community-acquired pneumonia with oral amoxicillin in under-five children in developing country: a systematic review.
title_fullStr Treatment of severe community-acquired pneumonia with oral amoxicillin in under-five children in developing country: a systematic review.
title_full_unstemmed Treatment of severe community-acquired pneumonia with oral amoxicillin in under-five children in developing country: a systematic review.
title_short Treatment of severe community-acquired pneumonia with oral amoxicillin in under-five children in developing country: a systematic review.
title_sort treatment of severe community acquired pneumonia with oral amoxicillin in under five children in developing country a systematic review
url http://europepmc.org/articles/PMC3692509?pdf=render
work_keys_str_mv AT rashmiranjandas treatmentofseverecommunityacquiredpneumoniawithoralamoxicillininunderfivechildrenindevelopingcountryasystematicreview
AT meenusingh treatmentofseverecommunityacquiredpneumoniawithoralamoxicillininunderfivechildrenindevelopingcountryasystematicreview